FACTBOX-GLOBAL DRUGMAKERS RUSH TO BOOST US PRESENCE AS TARIFF THREAT LOOMS
https://s.yimg.com/ny/api/res/1.2/7q66wxCIx9bmfJnG9pnyDA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2025-10/4da566c0-adfa-11f0-b7b3-bad733c85d90
βοΈ Global drugmakers are rushing to boost US manufacturing and inventory as the Trump administration weighs a 100% tariff on imported branded and patented drugs.
π Pfizer secured a deal with President Trump to invest $70 billion in research and development and domestic manufacturing π Eli Lilly will invest $5 billion to build a manufacturing facility in Virginia π Johnson & Johnson plans to raise US investments by 25%, totaling $55 billion, over the next four years π Roche will invest $50 billion in the US over the next five years π AstraZeneca will invest $50 billion on US manufacturing by 2030
-- #PresidentDonaldTrump #ThomasSchinecker(RocheCEO) #FranΓ§oisRoger(SanofiCFO) #RobertDavis(MerckCEO) #UnitedStates #Virginia #NorthCarolina #London #Tokyo #HollySprings #Indiana #Pennsylvania #Massachusetts #California #Maryland #Texas #SanDiego #FosterCity #FallRiver #CentralIslip #Bengaluru #business
Loading quoted postβ¦


















